Publikationen von Schenk, Michael

Heinrich, Kathrin, Modest, Dominik Paul, Ricard, Ingrid, Fischer von Weikersthal, Ludwig, Decker, Thomas, Vehling-Kaiser, Ursula, Graeven, Ullrich, Uhlig, Jens, Schenk, Michael, Freiberg-Richter, Jens, Peuser, Bettina, Denzlinger, Claudio, Peveling genannt Reddemann, Christina, Giessen-Jung, Clemens, Stahler, Arndt, Held, Swantje, Jung, Andreas, Kirchner, Thomas, Stintzing, Sebastian und Heinemann, Volker (2019) Gender and survival benefit from initial irinotecan in metastatic colorectal cancer: Analysis of the XELAVIRI (AIOKRK0110) study. Journal of Clinical Oncology 37 (15_sup), S. 3559. Volltext nicht vorhanden.

Al-Batran, Salah-Eddin, Pauligk, Claudia, Hofheinz, Ralf, Lorenzen, Sylvie, Wicki, Andreas, Siebenhuener, Alexander Rheinhard, Schenk, Michael, Welslau, Manfred, Heuer, Vera, Goekkurt, Eray, Schmalenberg, Harald, Thuss-Patience, Peter C., Waberer, Lisa, Talbot, Jonathan, Goetze, Thorsten Oliver und Homann, Nils (2019) Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: DANTE, a randomized, open-label phase II trial of the German Gastric Group of the AIO and the SAKK. Journal of Clinical Oncology 37 (15_sup), TPS4142-TPS4142. Volltext nicht vorhanden.

Al-Batran, Salah-Eddin, Homann, Nils, Pauligk, Claudia, Goetze, Thorsten O., Meiler, Johannes, Kasper, Stefan, Kopp, Hans-Georg, Mayer, Frank, Haag, Georg Martin, Luley, Kim, Lindig, Udo, Schmiegel, Wolff, Pohl, Michael, Stoehlmacher, Jan, Folprecht, Gunnar, Probst, Stephan, Prasnikar, Nicole, Fischbach, Wolfgang, Mahlberg, Rolf, Trojan, Jörg, Koenigsmann, Michael, Martens, Uwe M., Thuss-Patience, Peter, Egger, Matthias, Block, Andreas, Heinemann, Volker, Illerhaus, Gerald, Moehler, Markus, Schenk, Michael, Kullmann, Frank, Behringer, Dirk M., Heike, Michael, Pink, Daniel, Teschendorf, Christian, Löhr, Carmen, Bernhard, Helga, Schuch, Gunter, Rethwisch, Volker, von Weikersthal, Ludwig Fischer, Hartmann, Jörg T., Kneba, Michael, Daum, Severin, Schulmann, Karsten, Weniger, Jörg, Belle, Sebastian, Gaiser, Timo, Oduncu, Fuat S., Güntner, Martina, Hozaeel, Wael, Reichart, Alexander, Jäger, Elke, Kraus, Thomas, Mönig, Stefan, Bechstein, Wolf O., Schuler, Martin, Schmalenberg, Harald und Hofheinz, Ralf D. (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. The Lancet 393 (10184), S. 1948-1957. Volltext nicht vorhanden.

Modest, Dominik Paul, Fischer von Weikersthal, Ludwig, Decker, Thomas, Vehling-Kaiser, Ursula, Uhlig, Jens, Schenk, Michael, Freiberg-Richter, Jens, Peuser, Bettina, Denzlinger, Claudio, Peveling genannt Reddemann, Christina, Graeven, Ullrich, Schuch, Gunter, Schwaner, Ingo, Stahler, Arndt, Jung, Andreas, Kirchner, Thomas, Held, Swantje, Stintzing, Sebastian, Giessen-Jung, Clemens und Heinemann, Volker (2019) Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study—XELAVIRI (AIO KRK0110). Journal of Clinical Oncology 37 (1), S. 22-32. Volltext nicht vorhanden.

Michel, Christian, Burchert, Andreas, Hochhaus, Andreas, Saussele, Susanne, Neubauer, Andreas, Lauseker, Michael, Krause, Stefan W., Kolb, Hans-Jochem, Hossfeld, Dieter Kurt, Nerl, Christoph, Baerlocher, Gabriela M., Heim, Dominik, Brümmendorf, Tim H., Fabarius, Alice, Haferlach, Claudia, Schlegelberger, Brigitte, Balleisen, Leopold, Goebeler, Maria-Elisabeth, Hänel, Mathias, Ho, Anthony, Dengler, Jolanta, Falge, Christiane, Möhle, Robert, Kremers, Stephan, Kneba, Michael, Stegelmann, Frank, Köhne, Claus-Henning, Lindemann, Hans-Walter, Waller, Cornelius F., Spiekermann, Karsten, Berdel, Wolfgang E., Müller, Lothar, Edinger, Matthias, Mayer, Jiri, Beelen, Dietrich W., Bentz, Martin, Link, Hartmut, Hertenstein, Bernd, Fuchs, Roland, Wernli, Martin, Schlegel, Frank, Schlag, Rudolf, de Wit, Maike, Trümper, Lorenz, Hebart, Holger, Hahn, Markus, Thomalla, Jörg, Scheid, Christof, Schafhausen, Philippe, Verbeek, Walter, Eckart, Michael J., Gassmann, Winfried, Schenk, Michael, Brossart, Peter, Wündisch, Thomas, Geer, Thomas, Bildat, Stephan, Schäfer, Erhardt, Hasford, Joerg, Hehlmann, Rüdiger und Pfirrmann, Markus (2018) Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV. Haematologica 104 (5), S. 955-962. Volltext nicht vorhanden.

Lordick, Florian, Kunzmann, Volker, Trojan, Jorg, Daum, Severin, Schenk, Michael, Kullmann, Frank, Schroll, Sebastian, Behringer, Dirk M., Stahl, Michael, Al-Batran, Salah-Eddin, Ibach, Stefan, Koerfer, Justus und Knoedler, Maren Kristina (2018) Intraperitoneal immunotherapy with the bispecific anti-EpCAM x anti-CD3 directed antibody catumaxomab for patients with peritoneal carcinomatosis from gastric cancer: Final results of a randomized phase II AIO trial. Journal of Clinical Oncology 36 (4_supp), S. 4. Volltext nicht vorhanden.

Knödler, Maren, Körfer, Justus, Kunzmann, Volker, Trojan, Jörg, Daum, Severin, Schenk, Michael, Kullmann, Frank, Schroll, Sebastian, Behringer, Dirk, Stahl, Michael, Al-Batran, Salah-Eddin, Hacker, Ulrich, Ibach, Stefan, Lindhofer, Horst und Lordick, Florian (2018) Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer. British Journal of Cancer 119 (3), S. 296-302. Volltext nicht vorhanden.